Peter Staller

3.2k citations
14 papers · 2.7k · 1 hit paper · h-index 12

Impact in

  • Oncology top 5%
    • Cancer-related Molecular Pathways
    • Chemokine receptors and signaling
    • Cancer, Hypoxia, and Metabolism

Papers in

    • Cancer-related Molecular Pathways 4
    • Chemokine receptors and signaling 2
    • Cancer, Hypoxia, and Metabolism 1
    • Protease and Inhibitor Mechanisms 1

Peter Staller

14 papers receiving 2.6k citations

Peter Staller's Hit Papers

Chemokine receptor CXCR4 downregulated by von Hippel–Lindau tumour suppressor pVHL 2003 · 754 citations
7540+7+15Years since publication250500750

Peers

Peter Staller
Comparison fields: 5 of 81
  • Oncology 807
  • Cancer Research 419
  • Molecular Biology 1.2k
  • Pulmonary and Respiratory Medicine 276
  • Genetics 66
Replace Peter J. Hurlin with:
Peter J. Hurlin United States
Jesús Pérez‐Losada Spain
Olga N. Aprelikova United States
Frank Bartel Germany
Mario Cioce Italy
Kim L. Mercer United States
Arturo Sala United Kingdom
Michèle Grieco Italy
Pau Castel United States
Peter Staller relative to Peter J. Hurlin United States Peter J. Hurlin's profile →
Citations per field
00.5×2×3.0×
Peter J. Hurlin · 1×
Citations per year

Countries citing papers authored by Peter Staller

Since Specialization
Citations

This map shows the geographic impact of Peter Staller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Staller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Staller more than expected).

Fields of papers citing papers by Peter Staller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Staller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Staller. The network helps show where Peter Staller may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter Staller, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter Staller Line = papers co-authored together Peter Staller links everyone, so they are left out of the graph.

All Works

14 of 14 papers shown
#Work
1
Chemokine receptor CXCR4 downregulated by von Hippel–Lindau tumour suppressor pVHL
Hit paper breakdown →
2003754
2 2001469
3 2001409
4 2008296
5 1998213
6 2013111
7 2011107
8 1999104
9 201495
10 200866
11 199765
12 201827
13 20106
14 20151

About Peter Staller

Peter Staller is a scholar working on Oncology, Cancer Research, Molecular Biology, Pulmonary and Respiratory Medicine and Nuclear Energy and Engineering, having authored 14 papers that have together received 2.7k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (4 papers), Cancer-related Molecular Pathways (4 papers), Chemokine receptors and signaling (2 papers), Renal cell carcinoma treatment (2 papers), Cancer, Hypoxia, and Metabolism (1 paper), Protease and Inhibitor Mechanisms (1 paper), TGF-β signaling in diseases (1 paper) and FOXO transcription factor regulation (1 paper). The work is most often cited by research in Oncology (807 citations), Cancer Research (419 citations), Molecular Biology (1.2k citations), Pulmonary and Respiratory Medicine (276 citations) and Genetics (66 citations). Peter Staller has collaborated with scholars based in Germany, Denmark and United States. Frequent co-authors include Martin Eilers, Holger Moch, Wilhelm Krek, Edward J. Oakeley, Joanna Hergovich Lisztwan, Joan Seoane, Joan Massagué, Caroline Bouchard, Célio Pouponnot and Kim Steen Jensen. Their work appears in journals such as Oncogene, Nature Cell Biology, The Journal of Pathology, The EMBO Journal and Trends in Cell Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact